Delivery Order SPE2DB24D8003-SPE2DB25FJUKF

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,095.34, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is for the delivery of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a prescription medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, worth $999,999,999.00. The IDC falls under the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
The Defense Logistics Agency (DLA) awarded a $3,689.76 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This order is part of Dakota Drug's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and simulation equipment for...
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJUHD, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award is for the delivery of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML, with a ceiling value of $5,462.78 and an ultimate completion date of April 30, 2025. The contract is a delivery order under Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The award, with a ceiling value of $1,844.88, is for the delivery of the pharmaceutical product Mounjaro 7.5 mg/0.5 ml pen. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00. This IDC is part...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,500.92 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of MOUNJARO 5 MG/0.5 ML PEN 0.5ML medical supplies. This award is part of Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, under the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date of March 11,...
This federal contract award SPE2DB24D8003|SPE2DB25FJUFQ was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,188.84 firm fixed price delivery order is for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This award is not associated with a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. for the DLA Troop Support Medical's...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a Delivery Order valued at $2,397.84 for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 16, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly supporting U.S. Armed...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, with a ceiling value of $1,163.22, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA identified as SPE2DB24D8001. This IDC, valued at $999,999,999.00, is part of the DLA Troop Support Medical's ECAT Generation V Program and allows Dakota Drug, Inc. to provide a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJUKF
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $3,566.52 firm fixed price delivery order is for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML.

The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The original solicitation, SPE2DH-21-R-0002, sought proposals for commercial medical equipment, accessories, consumables, and medical simulation equipment used by medical professionals.

The contract award is not set aside for any particular business classification. Dakota Drug, Inc. has established itself as a critical vendor for medical procurement, particularly for the DLA, through its ability to efficiently deliver a diverse array of medications and medical supplies to various defense healthcare facilities.

Generated 8/17/25, 12:47 AM